ROUTE
CONTACT
FOLLOW US:
HOME
PRODUCTS
RESEARCH & DEVELOPMENT
PARTNERING
INVESTORS
ABOUT US
NEWS
Our team
Our team
Dominique de Kleijn - Chief Technology Officer (CTO)
Dominique de Kleijn, PhD, is a Professor of the
Experimental Cardiology Laboratory
at
UMCU
and co-initiator of the
Athero-Express Biobank Studies
. Dominique is project leader of the
Interuniversity Cardiology Institute of the Netherlands (ICIN)
. As a molecular biologist with a BSc in chemistry he performed the proteomics studies of the Athero-Express. His
research focus (>100 papers)
is the role of the innate immune system in the response to injury during
atherogenesis
and after myocardial infarction.
About us
OVERVIEW
MISSION
SUPERVISORY BOARD
OUR TEAM
CAREERS
Related items
Our mission
Cavadis is a Dutch biomedical company active in the field of cardiovascular risk assessment. The company's mission is to identify patients at risk of developing heart attacks and strokes. Our ultimate goal is to develop clinically meaningful risk stratification tools that will help personalize treatment and achieve better patient outcomes.
read more